Soft Tissue Sarcoma Clinical Trials

A listing of Soft Tissue Sarcoma medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 23 clinical trials
Featured trial
Formal Test 5

Formal Test 5Formal Test 5Formal Test 5

  • 0 views
  • 19 Feb, 2024
  • 1 location
Featured trial
Formal Test 6

Formal Test 6Formal Test 6Formal Test 6Formal Test 6Formal Test 6Formal Test 6Formal Test 6

  • 0 views
  • 19 Feb, 2024
  • 1 location
Featured trial
Formal Test 7  

Formal Test 7Formal Test 7Formal Test 7Formal Test 7Formal Test 7Formal Test 7Formal Test 7Formal Test 7Formal Test 7Formal Test 7Formal Test 7Formal Test 7

  • 0 views
  • 19 Feb, 2024
  • 1 location
A Study Evaluating The Safety Tolerability Pharmacokinetics And Efficacy Of Venetoclax In Combination With Atezolizumab Carboplatin And Etoposide In Participants With Untreated Extensive-Stage Small Cell Lung Cancer (ES-SCLC).

A study consisting of a dose-escalation phase and a dose-expansion phase to evaluate the safety, tolerability, pharmacokinetics, and efficacy of venetoclax in combination with atezolizumab, carboplatin, and etoposide.

metastasis
cns metastases
chemoradiotherapy
gcsf
atezolizumab
  • 0 views
  • 19 Feb, 2024
A Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Patients With Untreated Extensive-Stage Small Cell Lung Cancer

extensive-stage small cell lung cancer (ES-SCLC). Eligible participants will be randomized in a 1:1 ratio to receive one of the following treatment regimens during induction phase:- Arm A

small cell lung cancer
atezolizumab
maintenance therapy
solid tumour
extensive stage sclc
  • 0 views
  • 19 Feb, 2024
Neoadjuvant Irradiation of Retroperitoneal Soft Tissue Sarcoma With Ions Retro-Ion

guidance of the retroperitoneal Sarcomas using protons or carbon ions before a subsequent tumor resection.

  • 0 views
  • 19 Feb, 2024
MEK Inhibitor and a PDL1 Inhibitor Patients With Locally Advanced and/or Metastatic Soft Tissue Sarcoma

clinical activity of atezolizumab + cobimetinib in advanced/metastatic soft tissue sarcomas.

metastasis
atezolizumab
adjuvant
anthracyclines
epithelioid sarcomas
  • 0 views
  • 19 Feb, 2024
Patients With ES-SCLC and ECOG PS=2 Receiving Atezolizumab-Carboplatin-Etoposide

Small cell lung cancer (SCLC) is a rapidly proliferating, neuroendocrine tumor that accounts for about 15% of all lung cancers. Most patients have metastases at primary diagnosis involving sites like bone, adrenal glands, liver and brain. Compared with non-small-cell lung cancer (NSCLC) SCLC has a unique natural history with a …

cns metastases
systemic disease
immunosuppressive
atezolizumab
liver metastasis
  • 0 views
  • 19 Feb, 2024
Targeting CD276 (B7-H3) Positive Solid Tumors by 4SCAR-276

Patients with refractory and/or recurrent solid tumor have poor prognosis despite complex multimodel therapy and therefore, novel approaches are urgently needed. This study attempts to treat these diseases using T cells genetically modified with a 4th generation lentiviral chimeric antigen receptor (4SCAR fused with an inducible apoptotic caspase 9 domain) …

metastasis
kidney function test
blood transfusion
platelet count
tyrosine
  • 0 views
  • 19 Feb, 2024
Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial Cancer

A study to assess the efficacy and safety of durvalumab in combination with platinum-based chemotherapy (paclitaxel + carboplatin) followed by maintenance durvalumab with or without olaparib for patients with newly diagnosed advanced or recurrent endometrial cancer.

carcinosarcoma
adjuvant
recurrent disease
carcinoma
endometrial carcinoma
  • 0 views
  • 19 Feb, 2024